Merck Frosst
Patients & Caregivers Contact Us Français
Patients & CaregiversContact UsFrançais
Home

RECOMBIVAX HB®

(hepatitis B vaccine [recombinant])

Disclaimer

Original Notice of Compliance (NoC)

RECOMBIVAX HB®: May 11, 1987
HEPTAVAX-B®: October 1982

Therapeutic / Pharmacological Classification

Vaccine for Active Immunization Against Infection Caused by Hepatitis B Virus Including All Known Subtypes

Product Monograph / Prescribing Information / Product Information

Download   Date of approval: March 23, 2009 (09,03-a_126922)
File name: RECOMBIVAX_HB-09_03-a_126922_E.pdf
File size: 274 KB


CONSUMER INFORMATION

Download   Date of approval: March 23, 2009 (09,03-a_126922)
File name: RECOMBIVAX_HB-09_03-a_126922_CI_E.pdf
File size: 127 KB

This file is presented in PDF format. This software is available at no charge through the Adobe Web site. Get Adobe Reader

DISCLAIMER
The contents of this site, including but not limited to Merck Frosst product information and product monographs, are for informational purposes only and are intended solely for residents of Canada, and are not intended, nor should they be used, as a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician, pharmacist or other qualified health care provider with any questions you may have regarding a medical condition.


® Registered Trademark of Merck & Co., Inc. Used under license.

Printer friendly
Email a friend

This site is for residents of Canada. / This site was updated on August 25, 2010.